Immune alterations and immunotherapy prospects in head and neck cancer

By Varilla Vincent  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1241-1256

Informa Healthcare

Access to resources Recommend Favorite

Zalutumumab in head and neck cancer

By Schick Ulrike   Gujral Dorothy M   Richards Tom M   Harrington Kevin J   Nutting Christopher M  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 1, 2012-01 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite

Head and neck cancer: Gene therapy approaches. Part 1: Adenoviral vectors

By Nemunaitis John   O'Brien John  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 177-185

Informa Healthcare

Access to resources Recommend Favorite

Allelic loss at the GPx-1 locus in cancer of the head and neck

By Hu Ya   Dolan M.   Bae Richard   Yee Herman   Roy Martin   Glickman Robert   Kiremidjian-Schumacher Lidia   Diamond Alan  

Biological Trace Element Research, Vol. 101, Iss. 2, 2004-11 ,pp. : 97-106

Humana Press, Inc

Access to resources Recommend Favorite

PKCα take part in CCR7/NF-κB autocrine signaling loop in CCR7-positive squamous cell carcinoma of head and neck

By Zhen-jin Zhao   Peng Li   Fa-yu Liu   Liyan Sun   Chang-fu Sun  

Molecular and Cellular Biochemistry, Vol. 357, Iss. 1-2, 2011-11 ,pp. : 181-187

Springer Publishing Company

Access to resources Recommend Favorite